Amedisys (NASDAQ:AMED) Upgraded by StockNews.com to Buy

StockNews.com upgraded shares of Amedisys (NASDAQ:AMED – Free Report) from a hold rating to a buy rating in a report released on Saturday morning. A number of other brokerages also recently issued reports on AMED. Cantor Fitzgerald reiterated a neutral rating and set a $101.00 price target on shares of Amedisys in a research report […]

Related Keywords

United States ,Canada ,Raymond James ,Amedisys Company Profile ,Home Health ,Segantii Capital Management Ltd ,Westchester Capital Management ,Amedisys Inc ,Norges Bank ,Cantor Fitzgerald ,Water Island Capital ,Royal Bank ,Amedisys ,Free Report ,Get Free Report ,Capital Management ,Island Capital ,High Acuity ,Amedisys Daily ,